FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2063891666> ?p ?o ?g. }

• W2063891666 endingPage "97" @default.
• W2063891666 startingPage "93" @default.
• W2063891666 abstract "The recently discovered, vasoactive, cyclic undecapeptide human urotensin-II (hU-II), and its G-protein coupled receptor (GPR14) are both expressed in the human cardiovascular system. Little is known about the pathophysiological relevance of hU-II. We hypothesised that circulating hU-II is elevated in patients with coronary artery disease (CAD) corresponding to the degree of cardiac dysfunction.38 patients were diagnosed with coronary artery disease by left heart catheterization, and their functional status was classified according to the New York Heart Association (NYHA). hU-II-like immunoreactivity (hU-II-LI) was measured using a novel specific and sensitive enzyme-linked immunoassay. Calculations were performed with log-transformed hU-II-LI values.hU-II-LI correlated positively with left ventricular end diastolic pressure (LVEDP) (r=0.32, P=0.05) and tended to correlate inversely with left ventricular ejection fraction (LV-EF) (r=-0.31, P=0.061). There was a positive correlation between hU-II-LI and NYHA class (r=0.53, P=0.001). Circulating hU-II-LI was significantly higher in patients with NYHA class III (4822+/-723 pg/ml, N=13) than in patients with class I (1884+/-642 pg/ml, N=9, P=0.007) or class II (2294+/-426 pg/ml, N=15, P=0.046). There was no difference between classes I and II (P=0.83). Furthermore, hU-II-LI correlated significantly with B-type natriuretic peptide, a marker for heart failure (r=0.40, P=0.025). In a linear regression analysis, NYHA class was the only significant independent predictor of hU-II-LI.The present study demonstrates that plasma hU-II-LI rises significantly in proportion to parameters of cardiac dysfunction and functional impairment in patients with coronary artery disease. These results suggest a pathophysiological role for hU-II in cardiac disease and warrant further investigation." @default.
• W2063891666 created "2016-06-24" @default.
• W2063891666 creator A5023874489 @default.
• W2063891666 creator A5039050392 @default.
• W2063891666 creator A5042187230 @default.
• W2063891666 creator A5049262407 @default.
• W2063891666 creator A5052178369 @default.
• W2063891666 creator A5064435807 @default.
• W2063891666 creator A5068988120 @default.
• W2063891666 creator A5078886484 @default.
• W2063891666 creator A5081453631 @default.
• W2063891666 date "2004-03-01" @default.
• W2063891666 modified "2023-09-25" @default.
• W2063891666 title "Elevated plasma human urotensin-II-like immunoreactivity in ischemic cardiomyopathy" @default.
• W2063891666 cites W1486256755 @default.
• W2063891666 cites W1507859731 @default.
• W2063891666 cites W1974828530 @default.
• W2063891666 cites W2008284738 @default.
• W2063891666 cites W2019209509 @default.
• W2063891666 cites W2020466261 @default.
• W2063891666 cites W2041736813 @default.
• W2063891666 cites W2048164304 @default.
• W2063891666 cites W2063808488 @default.
• W2063891666 cites W2075733166 @default.
• W2063891666 cites W2085855801 @default.
• W2063891666 cites W2102027030 @default.
• W2063891666 cites W2111985967 @default.
• W2063891666 cites W2133820979 @default.
• W2063891666 cites W2140228755 @default.
• W2063891666 cites W2145043050 @default.
• W2063891666 cites W2149322442 @default.
• W2063891666 cites W2152996717 @default.
• W2063891666 cites W2317695933 @default.
• W2063891666 cites W2340050819 @default.
• W2063891666 doi "https://doi.org/10.1016/j.ijcard.2003.05.008" @default.
• W2063891666 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14996481" @default.
• W2063891666 hasPublicationYear "2004" @default.
• W2063891666 type Work @default.
• W2063891666 sameAs 2063891666 @default.
• W2063891666 citedByCount "70" @default.
• W2063891666 countsByYear W20638916662013 @default.
• W2063891666 countsByYear W20638916662014 @default.
• W2063891666 countsByYear W20638916662015 @default.
• W2063891666 countsByYear W20638916662016 @default.
• W2063891666 countsByYear W20638916662017 @default.
• W2063891666 countsByYear W20638916662019 @default.
• W2063891666 countsByYear W20638916662020 @default.
• W2063891666 countsByYear W20638916662021 @default.
• W2063891666 crossrefType "journal-article" @default.
• W2063891666 hasAuthorship W2063891666A5023874489 @default.
• W2063891666 hasAuthorship W2063891666A5039050392 @default.
• W2063891666 hasAuthorship W2063891666A5042187230 @default.
• W2063891666 hasAuthorship W2063891666A5049262407 @default.
• W2063891666 hasAuthorship W2063891666A5052178369 @default.
• W2063891666 hasAuthorship W2063891666A5064435807 @default.
• W2063891666 hasAuthorship W2063891666A5068988120 @default.
• W2063891666 hasAuthorship W2063891666A5078886484 @default.
• W2063891666 hasAuthorship W2063891666A5081453631 @default.
• W2063891666 hasConcept C10162356 @default.
• W2063891666 hasConcept C126322002 @default.
• W2063891666 hasConcept C164705383 @default.
• W2063891666 hasConcept C170493617 @default.
• W2063891666 hasConcept C178853913 @default.
• W2063891666 hasConcept C2775915353 @default.
• W2063891666 hasConcept C2777385415 @default.
• W2063891666 hasConcept C2778198053 @default.
• W2063891666 hasConcept C2778213512 @default.
• W2063891666 hasConcept C2778797674 @default.
• W2063891666 hasConcept C2779935178 @default.
• W2063891666 hasConcept C48277249 @default.
• W2063891666 hasConcept C57900726 @default.
• W2063891666 hasConcept C71924100 @default.
• W2063891666 hasConcept C78085059 @default.
• W2063891666 hasConcept C84393581 @default.
• W2063891666 hasConceptScore W2063891666C10162356 @default.
• W2063891666 hasConceptScore W2063891666C126322002 @default.
• W2063891666 hasConceptScore W2063891666C164705383 @default.
• W2063891666 hasConceptScore W2063891666C170493617 @default.
• W2063891666 hasConceptScore W2063891666C178853913 @default.
• W2063891666 hasConceptScore W2063891666C2775915353 @default.
• W2063891666 hasConceptScore W2063891666C2777385415 @default.
• W2063891666 hasConceptScore W2063891666C2778198053 @default.
• W2063891666 hasConceptScore W2063891666C2778213512 @default.
• W2063891666 hasConceptScore W2063891666C2778797674 @default.
• W2063891666 hasConceptScore W2063891666C2779935178 @default.
• W2063891666 hasConceptScore W2063891666C48277249 @default.
• W2063891666 hasConceptScore W2063891666C57900726 @default.
• W2063891666 hasConceptScore W2063891666C71924100 @default.
• W2063891666 hasConceptScore W2063891666C78085059 @default.
• W2063891666 hasConceptScore W2063891666C84393581 @default.
• W2063891666 hasIssue "1" @default.
• W2063891666 hasLocation W20638916661 @default.
• W2063891666 hasLocation W20638916662 @default.
• W2063891666 hasOpenAccess W2063891666 @default.
• W2063891666 hasPrimaryLocation W20638916661 @default.
• W2063891666 hasRelatedWork W1949634191 @default.
• W2063891666 hasRelatedWork W1964205598 @default.
• W2063891666 hasRelatedWork W2035449108 @default.

• next